World Biobanking Industry Analysed by CBR Pharma Insights in Topical Research Report Available at MarketPublishers.com13 Jan 2016 • by Natalie Aster
LONDON – The significance of biobanks lies in determining the most efficient way to store the collected human biospecimens and related information and make it available upon request. Biobanks may collect different samples from diseased or healthy individuals in various settings. The integration of cutting-edge tools like big data techniques, in tandem with the growing industry needs for top-quality biospecimens for research, will likely to result in the expansion of the biospecimen collections, eventually contributing to this sector growth. To date, there are biobanks on practically every continent, with the majority of them being located in North America as well as Europe. Australia has the highest number of biobanks across the APAC region while India boasts of having the largest number of biobanks, when taking in consideration only the developing economies.
Biobanks’ development depends on people's desire to donate their samples for R&D and to agree to the storage of these samples. The participation and support of the public is hence of key importance as their attitude toward biobanking activities is expected to determine the success of a host of these organisations.
Topical study “Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future” elaborated by CBR Pharma Insights provides keen insights into the global biobanking industry, covering fundamental concepts in biobanking, classification of biobanks, and key challenges (economic, ethical and technological) that face these organisations, as well as including best practice guidelines and strategic recommendations. The report sheds light on the role of biobanks in R&D. It includes a granular analysis on the number of biobanks in the key regions and nations; discusses technology advances in specimen collection, storage, consumables, data handling, biospecimen transportation, etc. The research report takes a detailed look at the different public concerns on biobanking, their attitude toward research, and also how these issues can be addressed via technology adoption and novel frameworks. The study provides analysis on regulatory, ethical and harmonisation requirements in the biobanking industry.
Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future
Published: December, 2015
Price: US$ 2,995.00
More studies by the publisher can be found at CBR Pharma Insights page.